ATS Breathe Easy

American Thoracic Society
  • 0.0 (0)
  • 醫學
  • 每星期更新

Conversations in Pulmonary, Critical Care and Sleep Medicine by the American Thoracic Society

  1. ATS Breathe Easy - Innovations in Idiopathic Pulmonary Fibrosis Care

    4日前

    ATS Breathe Easy - Innovations in Idiopathic Pulmonary Fibrosis Care

    Idiopathic pulmonary fibrosis (IPF) is a progressive and often fatal lung disease, which has unknown causes and no cure. But researchers are working tirelessly to uncover more about this deadly disease. On this episode of the ATS Breathe Easy podcast, host Patti Tripathi interviews pulmonologist and transplant specialist Steven Nathan, MD, about advances in the treatment IPF, the importance of earlier diagnosis, ongoing challenges in treatment and lung transplantation, and promising results from the Phase 3 TETON clinical trials of inhaled treprostinil, which could become a fourth approved therapy for IPF. This episode is sponsored by United Therapeutics.

    18 分鐘
  2. ATS Breathe Easy - ATS 2026: How a Rare Genetic Disorder Could Change Lung Disease Care

    6月30日

    ATS Breathe Easy - ATS 2026: How a Rare Genetic Disorder Could Change Lung Disease Care

    Hermansky-Pudlak syndrome (HPS) is a rare genetic disorder that causes albinism, bleeding problems, and a high risk of developing pulmonary fibrosis. However, patients with HPS provide an important population for researchers looking for biomarkers that predict the onset and progression of pulmonary fibrosis. On this ATS Breathe Easy podcast episode, expert Resat Cinar, PhD, MBA, National Institute on Alcohol Abuse and Alcoholism, and patient advocate and founder of the Hermansky-Pudlak Syndrome Network Donna Appell, RN, discuss how HPS has helped researchers better understand pulmonary fibrosis, and how research on rare diseases can generate insights that benefit much larger patient populations.

    21 分鐘
  3. ATS Breathe Easy - Understanding NTM Lung Disease

    6月23日

    ATS Breathe Easy - Understanding NTM Lung Disease

    On this episode of the ATS Breathe Easy podcast, delve into journalist Terry Greene Sterling’s journey of being diagnosed with nontuberculous mycobacterial (NTM) lung disease. Greene Sterling's piece on living with NTM lung disease, funded by the Pulitzer Center, recently aired on KJZZ, the NPR affiliate in Phoenix. Host Patti Tripathi also interviews NTM specialist and Greene Sterling’s doctor, Charles Daley, MD, National Jewish Health, on the causes and symptoms of this disease. Learn how NTM is often missed in the initial screening, plus the environmental factors that can lead to infection, challenges in treatment, and the importance of ongoing research, public awareness, and clinician education. KJZZ Arizona Public Radio: https://www.linkedin.com/showcase/kjzz-91.5-fm-phoenix/ The Pulitzer Center: https://www.linkedin.com/company/pulitzer-center/ Conecta Arizona: https://www.linkedin.com/company/conectaarizona/ Terry Greene Sterling: https://www.linkedin.com/in/terrygreenesterling/ NTM Info and Research: https://www.linkedin.com/company/ntmir/ Bronchiectasis and NTM Association: https://www.linkedin.com/company/bronchiectasis-and-ntm-association/

    19 分鐘
  4. ATS Breathe Easy - ATS 2026: Delving into the Future of Rare Lung Disease

    6月16日

    ATS Breathe Easy - ATS 2026: Delving into the Future of Rare Lung Disease

    Lymphangioleiomyomatosis (LAM) is a rare lung disease that has become more treatable thanks to dedicated efforts from researchers and patient advocacy groups. ATS Past President Gregory Downey, MD, ATSF, National Jewish Health, discusses advances in understanding and treating LAM with host Ugo Ezema, MD. What role do patient networks play and what does the future hold for research?

    20 分鐘
  5. ATS Breathe Easy: Tackling Bacterial Pneumonia in ICU Patients

    6月9日

    ATS Breathe Easy: Tackling Bacterial Pneumonia in ICU Patients

    Hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) are serious conditions that often affect critically ill patients in ICUs. These infections carry a high risk of mortality and are frequently caused by multidrug-resistant bacteria like MRSA. On this episode of the ATS Breathe Easy podcast, Scott Micek, PharmD, University of Health Sciences and Pharmacy in St. Louis, explains to host Eddie Qian, MD, Vanderbilt University, why treating HABP/VABP needs to be tailored to the patient, how rapid diagnostics have pros and cons, and the importance of balancing aggressive early treatment with careful reassessment.   This episode is sponsored by Innoviva Specialty Therapeutics.

    28 分鐘

  6. 6月2日

    ATS Breathe Easy – Hantavirus: Beyond the Headlines with ATS Expert, Dr. Michelle Harkins

    When news of the Andes strain of the hantavirus broke out, the world seemed to hold its breath. But what do we know about the hantavirus? Expert Michelle Harkins, MD, University of New Mexico, discusses what the hantavirus is and how it is transmitted. She and host Ugo Ezema, MD, Tulane University, delve deeper at the ATS International Conference into how this hantavirus outbreak differs from the spread of COVID, what tests are used to detect hantavirus, and what research is happening in prevention and treatment of hantavirus.

    19 分鐘
  7. Re-Release: ATS Breathe Easy - ATS 2026 Keynotes Preview

    5月26日

    Re-Release: ATS Breathe Easy - ATS 2026 Keynotes Preview

    Host Ugo Ezema, MD, Tulane University, speaks with University of Cincinnati's Laurah Turner, PhD, one of ATS 2026's keynote speakers who addressed the hot topic of AI in medical education. Check out ATS NOW, tailored education anytime, anywhere. All #ATS2026 attendees get free access to this innovative, on-demand platform through the end of the year. Learn more: https://atsnow.thoracic.org/

    29 分鐘
  8. ATS Breathe Easy – How Pulse Oximeters Lead to Delayed Care for Patients of Color

    5月19日

    ATS Breathe Easy – How Pulse Oximeters Lead to Delayed Care for Patients of Color

    Pulse oximetry is a key technology, providing a quick, non-invasive way to estimate blood oxygen levels. But one issue with this tool is that it can overestimate oxygen levels in patients with darker skin pigmentation, which means they can appear less sick than they are, leading to delays in receiving treatments. Ashraf Fawzy, MD, MPH, Johns Hopkins Medicine, and host Eddie Qian, MD, Vanderbilt University, discuss how this disparity can affect patient care, the push to develop more broadly-tested equitable tools, and more on this episode of the ATS Breathe Easy podcast.

    29 分鐘
查看全部 (506)

關於

Conversations in Pulmonary, Critical Care and Sleep Medicine by the American Thoracic Society

資料

  • 創作者
    American Thoracic Society
  • 活躍年份
    2015年 - 2026年
  • 單集
    506
  • 分級
    兒童適宜
  • 版權
    © 2025 American Thoracic Society
  • 節目網站
    ATS Breathe Easy

你可能也會喜歡